L01FF PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors L4
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L4 · Search this class · Consumer categories
Active ingredients in this class
25 active ingredients 25 principios activos 25 个活性成分 25 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Nivolumab
L01FF01active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Atezolizumab
L01FF05active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Pembrolizumab
L01FF02active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Durvalumab
L01FF03active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG ES TW EU FR · discontinued MX · unknown HK - Avelumab
L01FF04active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG ES TW EU FR · discontinued MX · unknown HK - Dostarlimab
L01FF07active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES MX TW EU FR · unknown HK - Tislelizumab
L01FF09active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG CN ES TW EU · unknown HK - Cemiplimab
L01FF06active US GB CA AU ES · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA AU ES MX TW EU FR - Toripalimab
L01FF13active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG CN ES EU · unknown HK - Serplulimab
L01FF12active GB SG ES EU · and 2 more y 2 más 另有 2 个 另有 2 個
active GB SG ES EU · unknown HK - Retifanlimab
L01FF10active US CA EU · and 2 more y 2 más 另有 2 个 另有 2 個
active US CA EU · discontinued ES - Sugemalimab
L01FF11active MX EU · and 2 more y 2 más 另有 2 个 另有 2 個
active MX EU · discontinued ES - 贝莫苏拜单抗
L01FFactive CN
active CN - 恩朗苏拜单抗
L01FFactive CN
active CN - 索卡佐利单抗
L01FFactive CN
active CN - 卡瑞利珠单抗
L01FFactive CN
active CN - 普特利单抗
L01FFactive CN
active CN - 阿得贝利单抗
L01FFactive CN
active CN - 艾帕洛利托沃瑞利单抗
L01FFactive CN
active CN - 斯鲁利单抗
L01FFactive CN
active CN - 舒格利单抗
L01FFactive CN
active CN - 菲诺利单抗
L01FFactive CN
active CN - 卡度尼利单抗
L01FFactive CN
active CN - 塔戈利单抗
L01FFactive CN
active CN - 信迪利单抗
L01FFactive CN
active CN
By dosage form, across markets
Only ingredients with a recorded ATC class are listed (6,009 of 12,637).